Correlation Between Cannara Biotech and OrganiGram Holdings

Can any of the company-specific risk be diversified away by investing in both Cannara Biotech and OrganiGram Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannara Biotech and OrganiGram Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cannara Biotech and OrganiGram Holdings, you can compare the effects of market volatilities on Cannara Biotech and OrganiGram Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannara Biotech with a short position of OrganiGram Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannara Biotech and OrganiGram Holdings.

Diversification Opportunities for Cannara Biotech and OrganiGram Holdings

-0.27

Correlation Coefficient

Cannara Biotech  OrganiGram Holdings

Very good diversification

The 3 months correlation between Cannara and OrganiGram is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Cannara Biotech and OrganiGram Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OrganiGram Holdings and Cannara Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannara Biotech are associated (or correlated) with OrganiGram Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OrganiGram Holdings has no effect on the direction of Cannara Biotech i.e., Cannara Biotech and OrganiGram Holdings go up and down completely randomly.

Pair Corralation between Cannara Biotech and OrganiGram Holdings

Assuming the 90 days trading horizon Cannara Biotech is expected to under-perform the OrganiGram Holdings. In addition to that, Cannara Biotech is 1.84 times more volatile than OrganiGram Holdings. It trades about -0.01 of its total potential returns per unit of risk. OrganiGram Holdings is currently generating about 0.05 per unit of volatility. If you would invest  219.00  in OrganiGram Holdings on September 24, 2024 and sell it today you would earn a total of  6.00  from holding OrganiGram Holdings or generate 2.74% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Cannara Biotech  vs.  OrganiGram Holdings

Cannara Biotech

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Cannara Biotech are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Cannara Biotech showed solid returns over the last few months and may actually be approaching a breakup point.

OrganiGram Holdings

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days OrganiGram Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, OrganiGram Holdings is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Cannara Biotech and OrganiGram Holdings

The main advantage of trading using opposite Cannara Biotech and OrganiGram Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannara Biotech position performs unexpectedly, OrganiGram Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OrganiGram Holdings will offset losses from the drop in OrganiGram Holdings' long position.

The idea behind Cannara Biotech and OrganiGram Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.